Study 1161
We are looking for healthy individuals who would like to donate blood for a method development study.
The blood you donate will be used for research to develop new methods that could potentially be used in future treatments for cancer, autoimmune diseases, and other immunological conditions.
Target group: healthy individuals, ages 18–65
Criteria for participation:
- Be healthy
- Not treated with anti-inflammatory or immunosuppressive medications
- Not be pregnant, or intend to become pregnant, or be breastfeeding during the course of the study
The study consists of a telephone interview and a clinic visit. The clinic visit will take place at OptiCell Solutions in Huddinge and is expected to last about an hour. During the visit, you will be asked to provide up to 100 ml of blood from a vein in your arm.
Compensation:
300 SEK as compensation for your participation.
Available times:
| Time for a clinic visit |
| March 30 |
| April 13 |
| April 20 |
| April 27 |
| May 4 |
| May 11 |
More information and registration
Would you like to participate in the study? Submit an expression of interest using the form below.
Do you have questions or want to know more? Call 018-30 33 99 or email info@ctc-ab.se.
The study has been approved by the Ethical Review Authority. Your participation is voluntary, and you can withdraw at any time. The information you provide will be processed in accordance with the General Data Protection Regulation (GDPR).




